Published • loading... • Updated
Spanish Researchers Request European Patent Antithrombotic Therapy Based on Gene Editing of the F11 Gene
Summary by diarioestrategia.cl
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Research staff from the CIBER areas of Rare Diseases (CIBERER) and Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) have submitted a European patent application for innovative antithrombotic therapy based on gene editing of the F11 gene using CRISPR/Cas9 technology administered with lipid nanoparticles.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
